Health benefits of higher serum 25-hydroxyvitamin D levels in The Netherlands

Journal of Steroid Biochemistry and Molecular Biology

Volumn 121, Issue 1-2, 2010, Pages 456-458

  Grant, William B ^a   Schuitemaker, Gert E ^b  

^a Sunlight Nutrition and Health Research Center ^*  (United States)

^b Ortho Institute   (Netherlands)

Author keywords

Cancer; Cardiovascular disease; Cathelicidin; Infectious diseases; Ultraviolet B; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; ANTIMICROBIAL CATIONIC PEPTIDE; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; VITAMIN D;

ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BLOOD LEVEL; CANCER RISK; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; DEMENTIA; DIABETES MELLITUS; FALLING; FRACTURE; INCIDENCE; INFECTION RISK; MORTALITY; NETHERLANDS; OSTEOPOROSIS; VIRUS INFECTION; ADULT; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; DISEASES; GENETICS; HUMAN; INFECTION CONTROL; METABOLISM; MIDDLE AGED; PROCEDURES; RISK; ULTRAVIOLET RADIATION;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; CARDIOVASCULAR DISEASES; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DIET THERAPY; DIETARY SUPPLEMENTS; DISEASE; HUMANS; MIDDLE AGED; NETHERLANDS; RISK; ULTRAVIOLET RAYS; VITAMIN D;

BACTERIA (MICROORGANISMS);

EID: 77954761445     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.03.089     Document Type: Article

References (44)

1. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357(3):266-281.
2. Cannell J.J., Hollis B.W. Use of vitamin D in clinical practice. Altern. Med. Rev. 2008, 13(1):6-20.
3. Mookherjee N., Rehaume L.M., Hancock R.E. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007, 11(8):993-1004.
4. Jablonski N.G., Chaplin G. The evolution of human skin coloration. J. Hum. Evol. 2000, 39(1):57-106.
5. Gorham E.D., Garland C.F., Garland F.C., Grant W.B., Mohr S.B., Lipkin M., Newmark H.L., Giovannucci E., Wei M., Holick M.F. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am. J. Prev. Med. 2007, 32(3):210-216.
6. W.B. Grant, G.K. Schwalfenberg, S.J. Genuis, S.J. Whiting, An estimate of the economic burden and premature deaths due to vitamin D deficiency in Canada. Mol. Nutr. Food Res. 2010 Mar 29. [Epub ahead of print].
7. Lappe J.M., Travers-Gustafson D., Davies K.M., Recker R.R., Heaney R.P. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 2007, 85(6):1586-1591.
8. Parker J., Hashmi O., Dutton D., Mavrodaris A., Stranges S., Kandala N.B., Clarke A., Franco O.H. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010, 65(3):225-236.
9. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 2009, 57(9):1595-1603.
10. Visser M., Deeg D.J., Puts M.T., Seidell J.C., Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am. J. Clin. Nutr. 2006, 84(3):616-622. quiz 671-612.
11. Heaney R.P., Davies K.M., Chen T.C., Holick M.F., Barger-Lux M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77(1):204-210.
12. Grant W.B., Cross H.S., Garland C.F., Gorham E.D., Moan J., Peterlik M., Porojnicu A.C., Reichrath J., Zittermann A. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog. Biophys. Mol. Biol. 2009, 99(2-3):104-113.
13. Grant W.B., Garland C.F. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr. Cancer 2004, 48(2):115-123.
14. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 2008, 168(11):1174-1180.
15. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 2008, 168(12):1340-1349.
16. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J. Am. Geriatr. Soc. 2009, 57(9):1595-1603.
17. Semba R.D., Houston D.K., Bandinelli S., Sun K., Cherubini A., Cappola A.R., Guralnik J.M., Ferrucci L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 2010, 64(2):203-209.
18. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., Hu F.B. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29(3):650-656.
19. Knekt P., Laaksonen M., Mattila C., Harkanen T., Marniemi J., Heliovaara M., Rissanen H., Montonen J., Reunanen A. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008, 19(5):666-671.
20. Kirii K., Mizoue T., Iso H., Takahashi Y., Kato M., Inoue M., Noda M., Tsugane S. Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 2009, 52(12):2450-2542.
21. Grant W.B. Hypothesis-ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem. Photobiol. 2008, 84(2):356-365.
22. Grant W.B., Giovannucci E. The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermato-Endocrinology 2009, 1(4):215-219.
23. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010, (March). Epub.
24. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., Wong J.B., Egli A., Kiel D.P., Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009, 339:b3692.
25. Grant W.B. Does vitamin D reduce the risk of dementia?. J. Alzheimers Dis. 2009, 17(1):151-159.
26. Pilz S., Marz W., Wellnitz B., Seelhorst U., Fahrleitner-Pammer A., Dimai H.P., Boehm B.O., Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J. Clin. Endocrinol. Metab. 2008, 93(10):3927-3935.
27. Grant W.B. Solar ultraviolet-B irradiance and vitamin D may reduce the risk of septicemia. Dermato-Endocrinology 2009, 1(1):25-30.
28. Health Council of The Netherlands Towards an Adequate Intake of Vitamin D 2008, Health Council of The Netherlands, The Hague.
29. IARC Vitamin D and Cancer, IARC Working Group Reports 2008, International Agency for Research on Cancer, Lyon, France, 465 pp.
30. Grant W.B. A critical review of vitamin D and cancer: a report of the IARC Working Group on vitamin D. Dermato-Endocrinology 2009, 1(1):25-33.
31. Grant W.B., Boucher B.J. Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. Anticancer Res. 2009, 29(9):3597-3604.
32. Whiting S.J., Calvo M.S. Dietary recommendations for vitamin D: a critical need for functional end points to establish an estimated average requirement. J. Nutr. 2005, 135(2):304-309.
33. Whiting S.J., Calvo M.S. Dietary recommendations to meet both endocrine and autocrine needs of vitamin D. J. Steroid Biochem. Mol. Biol. 2005, 97(1-2):7-12.
34. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007, 85(1):6-18.
35. Seymour J.F., Gagel R.F., Hagemeister F.B., Dimopoulos M.A., Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann. Intern. Med. 1994, 121(9):633-640.
36. Grant W.B. In defense of the sun: an estimate of changes in mortality rates in the United States if mean serum 25-hydroxyvitamin D levels were raised to 45ng/mL by solar ultraviolet-B irradiance. Dermato-Endocrinology 2009, 1:207-214.
37. Porojnicu A.C., Dahlback A., Moan J. Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude. Adv. Exp. Med. Biol. 2008, 624:43-54.
38. Chang Y.M., Barrett J.H., Bishop D.T., Armstrong B.K., Bataille V., Bergman W., Berwick M., Bracci P.M., Elwood J.M., Ernstoff M.S., Gallagher R.P., Green A.C., Gruis N.A., Holly E.A., Ingvar C., Kanetsky P.A., Karagas M.R., Lee T.K., Le Marchand L., Mackie R.M., Olsson H., Osterlind A., Rebbeck T.R., Sasieni P., Siskind V., Swerdlow A.J., Titus-Ernstoff L., Zens M.S., Newton-Bishop J.A. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int. J. Epidemiol. 2009, 38(3):814-830.
39. IARC The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: a systematic review. Int. J. Cancer 2007, 120(5):1116-1122.
40. Rees J.L. Genetics of hair and skin color. Annu. Rev. Genet. 2003, 37:67-90.
41. Raimondi S., Sera F., Gandini S., Iodice S., Caini S., Maisonneuve P., Fargnoli M.C. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int. J. Cancer 2008, 122(12):2753-2760.
42. Grant W.B Critique of the International Agency for Research on Cancer meta-analyses of the association of sunbed use with risk of cutaneous malignant melanoma. Dermato-Endocrinology 2009, 1(6). Epub.
43. Veierød M.B., Adami H.O., Lund E., Armstrong B.K., Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol. Biomarkers Prev. 2010, 19(1):111-120.
44. World Health Organization, Causes of Death, 2004. (accessed 28.10.09). http://www.who.int/healthinfo/statistics/bodgbddeathdalyestimates.xls.